Oncolytics Biotech Inc.
About
1.05USD+0.11 +11.76%
Closed • Updated at 16:59 GMT+00:00Market Cap$124.73M
Volume1.56M
Beta0.96
RSI64.33
Oncolytics Biotech Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 26 2026
From Ambrx to Oncolytics: Why Jared Kelly Believes the Market May Be Missing the Bigger Oncology Story
May 22 2026
Oncolytics Biotech® to Present Data at ASCO 2026 Reinforcing Pelareorep’s Potential Across Gastrointestinal Tumors
May 4 2026
Oncolytics Biotech® Reports Durable Responses in Second-Line RAS-Mutant MSS Colorectal Cancer
Apr 27 2026
Oncolytics Aligns with FDA on Planned Pivotal Anal Cancer Study
Apr 6 2026
Oncolytics Biotech® Announces Type C FDA Meeting to Discuss Single-arm Registrational Pathway for Pelareorep in Anal Cancer
Recent Videos
Oncolytics Biotech
May 29, 2026
04 Mayo 26. Noticias acciones biotecnológicas. Resumen diario. #trading $XBI #biotechnews
May 04, 2026
CEO Chat with Jared Kelly, CEO of Oncolytics Biotech
May 01, 2026
항암치료, 30% 반응률 돌파! 새로운 희망이 온다
Apr 08, 2026
Community Chat
Ask AI
Try asking